However, when Cebpα is ablated in already existing leukemia in vivo, it does not change the overall survival or immunophenotype of these animals, this indicates that C/EBPα is not required for maintenance of MLL-ENL AML cells but has a defined role during leukemogenesis (66). The gene discussed is KMT2A; the disease is leukemia.